SANKYO PHARMA Trademark

Trademark Overview


On Tuesday, November 10, 1998, a trademark application was filed for SANKYO PHARMA with the United States Patent and Trademark Office. The USPTO has given the SANKYO PHARMA trademark a serial number of 75586071. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, August 4, 2007. This trademark is owned by Sankyo Company Limited. The SANKYO PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for contr...
sankyo pharma

General Information


Serial Number75586071
Word MarkSANKYO PHARMA
Filing DateTuesday, November 10, 1998
Status710 - CANCELLED - SECTION 8
Status DateSaturday, August 4, 2007
Registration Number2399082
Registration DateTuesday, October 31, 2000
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 8, 2000

Trademark Statements


Goods and ServicesCentral nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria 'vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents
Translation of Words in MarkThe English translation of the word "SANKYO" in the mark is "three partnership".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, August 4, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSankyo Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Party NameSankyo Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo
JP

Party NameSankyo Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Trademark Events


Event DateEvent Description
Saturday, August 4, 2007CANCELLED SEC. 8 (6-YR)
Thursday, August 10, 2006CASE FILE IN TICRS
Thursday, July 6, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 10, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 31, 2000REGISTERED-PRINCIPAL REGISTER
Tuesday, August 8, 2000PUBLISHED FOR OPPOSITION
Friday, July 7, 2000NOTICE OF PUBLICATION
Thursday, April 13, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 7, 2000EXAMINER'S AMENDMENT MAILED
Monday, December 13, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2000ASSIGNED TO EXAMINER
Wednesday, March 29, 2000Sec. 1(B) CLAIM DELETED
Wednesday, August 11, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 1999NON-FINAL ACTION MAILED
Friday, May 28, 1999ASSIGNED TO EXAMINER